Human MIF Antibody | R&D Systems MAB289 product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

R&D Systems

product type :

antibody

product name :

Human MIF Antibody

catalog :

MAB289

quantity :

100 ug (also 25 ug, 500 ug)

price :

359 USD

clonality :

monoclonal

host :

mouse

conjugate :

nonconjugated

clone name :

12302

reactivity :

human

application :

western blot, ELISA

citations: 16

Published Application/Species/Sample/Dilution	Reference
ELISA; human; loading ...; tbl 5	Kim J, Choi J, Hahn H, Lee Y, Yu D, Kim J. Association of Macrophage Migration Inhibitory Factor Polymorphisms with Total Plasma IgE Levels in Patients with Atopic Dermatitis in Korea. PLoS ONE. 2016;11:e0162477 pubmed publisher
	Oh H, Kwak J, Kim B, Jin H, Park W, Choi S, et al. Migration Inhibitory Factor in Conditioned Medium from Human Umbilical Cord Blood-Derived Mesenchymal Stromal Cells Stimulates Hair Growth. Cells. 2020;9: pubmed publisher
	Ha W, Sevim Nalkiran H, Zaman A, Matsuda K, Khasraw M, Nowak A, et al. Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF). Sci Rep. 2019;9:2905 pubmed publisher
	Kim B, Rongisch R, Hager S, Grieb G, Nourbakhsh M, Rennekampff H, et al. Macrophage Migration Inhibitory Factor in Acute Adipose Tissue Inflammation. PLoS ONE. 2015;10:e0137366 pubmed publisher
	Crabb J, Hu B, Crabb J, Triozzi P, Saunthararajah Y, Tubbs R, et al. iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors. PLoS ONE. 2015;10:e0135543 pubmed publisher
	Oliveira C, de Bock C, Molloy T, Sadeqzadeh E, Geng X, Hersey P, et al. Macrophage migration inhibitory factor engages PI3K/Akt signalling and is a prognostic factor in metastatic melanoma. BMC Cancer. 2014;14:630 pubmed publisher
	Schipper H, de Jager W, van Dijk M, Meerding J, Zelissen P, Adan R, et al. A multiplex immunoassay for human adipokine profiling. Clin Chem. 2010;56:1320-8 pubmed publisher
	Ren Y, Law S, Huang X, Lee P, Bacher M, Srivastava G, et al. Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma. Ann Surg. 2005;242:55-63 pubmed
	Ren Y, Lin C, Li Z, Chen X, Huang X, Lui V, et al. Up-regulation of macrophage migration inhibitory factor in infants with acute neonatal necrotizing enterocolitis. Histopathology. 2005;46:659-67 pubmed
	Wadgaonkar R, Dudek S, Zaiman A, Linz McGillem L, Verin A, Nurmukhambetova S, et al. Intracellular interaction of myosin light chain kinase with macrophage migration inhibition factor (MIF) in endothelium. J Cell Biochem. 2005;95:849-58 pubmed
	Matsumoto K, Maruyama N, Maruyama T, Ohnishi Y, Nonaka S, Inoshita A, et al. Elevated macrophage migration inhibitory factor (MIF) levels in the urine of patients with focal glomerular sclerosis. Clin Exp Immunol. 2005;139:338-47 pubmed
	Riedemann N, Guo R, Gao H, Sun L, Hoesel M, Hollmann T, et al. Regulatory role of C5a on macrophage migration inhibitory factor release from neutrophils. J Immunol. 2004;173:1355-9 pubmed
	Chuang C, Hung C, Tsai M, Yeh T, Chuang Y. High concentrations of circulating macrophage migration inhibitory factor in patients with severe blunt trauma: Is serum macrophage migration inhibitory factor concentration a valuable prognostic factor?. Crit Care Med. 2004;32:734-9 pubmed
	Ashcroft G, Mills S, Lei K, Gibbons L, Jeong M, Taniguchi M, et al. Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor. J Clin Invest. 2003;111:1309-18 pubmed
	Matsumoto K, Kanmatsuse K. Urinary levels of macrophage migration inhibitory factor in patients with IgA nephropathy. Nephron. 2002;92:309-15 pubmed
	Wang L, Das H, Kamath A, Li L, Bukowski J. Human V gamma 2V delta 2 T cells augment migration-inhibitory factor secretion and counteract the inhibitory effect of glucocorticoids on IL-1 beta and TNF-alpha production. J Immunol. 2002;168:4889-96 pubmed

product information

brand :

R&D Systems

master code :

MAB289

SKU :

MAB289-100

product name :

Human MIF Antibody

description :

The Human MIF Antibody from R&D Systems is a mouse monoclonal antibody to MIF. This antibody reacts with human. The Human MIF Antibody has been validated for the following applications: Western Blot, Simple Western.

target :

MIF

category :

Primary Antibodies

unit size :

100 ug (also 25 ug, 500 ug)

buffer :

Lyophilized from a 0.2 µm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 µm filtered solution in PBS.

clonality :

Monoclonal

clone :

12302

conjugate :

Unconjugated

host :

Mouse

immunogen :

E. coli -derived recombinant human MIF, Pro2-Ala115, Accession # P14174

isotype :

IgG1

purity :

Protein A or G purified from hybridoma culture supernatant

species :

Human

specificity :

Detects human MIF in Western blots. In Western blots, this antibody shows approximately 25% cross-reactivity with recombinant mouse MIF.

gene symbol :

MIF

catalog number base :

MAB289

accessionNumbers :

P14174

applications :

Western Blot, Simple Western

2020 USD :

339

2021 USD :

359 USD

alt names :

EC 5.3.2.1, EC 5.3.3.12, GIFmacrophage migration inhibitory factor, GLIF, Glycosylation-inhibiting factor, L-dopachrome isomerase, L-dopachrome tautomerase, macrophage migration inhibitory factor (glycosylation-inhibiting factor), MMIF, Phenylpyruvate tautomerase

storage :

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.